查看購物車
  • Simplified Chinese
  • English
封面
市場調查報告書
商品編碼
1628052

2025-2034 年可生物分解骨移植聚合物市場機會、成長動力、產業趨勢分析與預測

Biodegradable Bone Graft Polymers Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025-2034
出版日期: | 出版商: Global Market Insights Inc. | 英文 200 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

2024 年，全球可生物分解骨移植聚合物市場價值為7.331 億美元，預計2025 年至2034 年複合年成長率為7.4%。的上升推動的。

聚合物技術的進步正在改善可生物分解骨移植物的生物相容性和機械性能，使其更有效地促進骨再生。對環保和永續醫療解決方案的需求也推動了可生物分解聚合物的採用，它為傳統骨移植材料提供了對環境負責的替代品。此外，臨床進步和監管部門的批准增強了人們對這些材料的信心，鞏固了它們作為骨修復和再生中可行替代品的作用。

骨科和牙科手術的發生率不斷增加，通常需要高效的骨再生解決方案，進一步支撐了市場。隨著尋求骨折和牙種植等疾病治療的患者數量持續增加，對創新移植材料的需求不斷成長，推動了可生物分解骨移植聚合物市場的發展。

市場範圍
開始年份 2024年
預測年份 2025-2034
起始值 7.331 億美元
預測值 12億美元
複合年成長率 7.4%

合成聚合物領域預計將大幅成長，預計到 2034 年市場價值將達到 11 億美元，複合年成長率為 7.6%。合成的可生物分解聚合物，例如聚己內酯 (PCL) 和聚乳酸 (PLA)，由於其可客製化的特性而越來越受歡迎。這些材料可以客製化以提供特定的機械強度和分解率，使其成為骨科和牙科手術中精密應用的理想選擇。相較之下，殼聚醣和膠原蛋白等天然聚合物因其優異的生物相容性和促進組織再生的能力而受到重視，反映了生物衍生材料在醫療應用中的更廣泛趨勢。

2024 年，聯合重建領域佔據市場領先地位，佔有率為 40.1%，價值 2.726 億美元。由於人們越來越關注開發增強癒合和組織整合的聚合物，預計到 2034 年，該細分市場將以 7.7% 的複合年成長率成長。這些創新迎合了日益成長的患有關節相關問題的老齡化人口，凸顯了可生物分解骨移植在促進更快恢復和更好結果方面的關鍵作用。

2034年，美國可生物分解骨移植聚合物市場預計將達到5.431億美元，複合年成長率為7.4%。由於肌肉骨骼疾病發病率上升以及人口老化需要更多手術干預，骨科和牙科應用需求不斷成長，推動了該地區的成長。

目錄

第 1 章：方法與範圍

第 2 章：執行摘要

第 3 章：產業洞察

  • 產業生態系統分析
    • 影響價值鏈的因素
    • 利潤率分析
    • 干擾
    • 未來展望
    • 製造商
    • 經銷商
  • 供應商格局
  • 利潤率分析
  • 重要新聞和舉措
  • 監管環境
  • 衝擊力
  • 產業影響力
    • 成長動力
      • 骨科和牙科手術的發生率上升。
      • 對微創手術的需求不斷增加。
      • 聚合物技術和生物相容性的進步。
    • 市場挑戰
      • 監管障礙和漫長的核准流程。
  • 法規和市場影響
  • 波特的分析
  • PESTEL分析

第 4 章：競爭格局

  • 介紹
  • 公司市佔率分析
  • 競爭定位矩陣
  • 戰略展望矩陣

第 5 章：市場規模與預測：按聚合物分類，2021-2034 年

  • 主要趨勢
  • 合成的
    • 解放軍
    • PG
    • 聚己內酯
  • 自然的
    • 殼聚醣
    • 膠原

第 6 章：市場規模與預測：按應用分類，2021-2034 年

  • 主要趨勢
  • 關節重建
  • 脊椎
  • 顱顎面
  • 骨科生物製劑
  • 牙科
  • 其他

第 7 章：市場規模與預測：按地區分類，2021-2034 年

  • 主要趨勢
  • 北美洲
    • 美國
    • 加拿大
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 俄羅斯
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲
  • 拉丁美洲
    • 巴西
    • 墨西哥
  • MEA
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國

第 8 章：公司簡介

  • BMG Incorporated
  • Corbion NV
  • Evonik
  • Foster Corporation
  • KLS Martin
  • Lactel Absorbable Polymers
  • Medtronic
  • NuVasive
  • Polysciences
  • Zimmer Biomet
簡介目錄
Product Code: 2283

The Global Biodegradable Bone Graft Polymers Market was valued at USD 733.1 million in 2024 and is expected to grow at a 7.4% CAGR from 2025 to 2034. This growth is primarily driven by the increasing demand for minimally invasive surgeries and the rising prevalence of bone-related conditions, which are creating a significant need for advanced regenerative treatments.

Advances in polymer technology are improving the biocompatibility and mechanical properties of biodegradable bone grafts, making them more effective for bone regeneration. The demand for eco-friendly and sustainable medical solutions is also fueling the adoption of biodegradable polymers, which offer an environmentally responsible alternative to traditional bone graft materials. Additionally, clinical advancements and regulatory approvals are boosting confidence in these materials, solidifying their role as a viable alternative in bone repair and regeneration.

The market is being further supported by the increasing incidence of orthopedic and dental procedures, which often require efficient bone regeneration solutions. As the number of patients seeking treatments for conditions like fractures and dental implants continues to rise, the demand for innovative grafting materials is growing, driving the market for biodegradable bone graft polymers.

Market Scope
Start Year2024
Forecast Year2025-2034
Start Value$733.1 Million
Forecast Value$1.2 Billion
CAGR7.4%

The synthetic polymer segment is expected to grow significantly, with a projected market value of USD 1.1 billion by 2034 and a CAGR of 7.6%. Synthetic biodegradable polymers, such as polycaprolactone (PCL) and polylactic acid (PLA), are gaining popularity due to their customizable properties. These materials can be tailored to provide specific mechanical strength and degradation rates, making them ideal for precision applications in orthopedic and dental surgeries. In contrast, natural polymers like chitosan and collagen are valued for their excellent biocompatibility and ability to promote tissue regeneration, reflecting a broader trend toward biologically derived materials in medical applications.

The joint reconstruction segment led the market in 2024, holding a share of 40.1% and valued at USD 272.6 million. This segment is projected to grow at a CAGR of 7.7% through 2034, driven by the increasing focus on developing polymers that enhance healing and tissue integration. These innovations cater to a growing aging population with joint-related issues, highlighting the critical role of biodegradable bone grafts in promoting faster recovery and better outcomes.

U.S. biodegradable bone graft polymers market is expected to reach USD 543.1 million by 2034, expanding at a CAGR of 7.4%. Growth in this region is being fueled by rising demand in orthopedic and dental applications, driven by a higher incidence of musculoskeletal disorders and an aging population that requires more surgical interventions.

Table of Contents

Chapter 1 Methodology & Scope

  • 1.1 Market scope & definition
  • 1.2 Base estimates & calculations
  • 1.3 Forecast calculation
  • 1.4 Data sources
    • 1.4.1 Primary
    • 1.4.2 Secondary
      • 1.4.2.1 Paid sources
      • 1.4.2.2 Public sources

Chapter 2 Executive Summary

  • 2.1 Industry synopsis, 2021-2034

Chapter 3 Industry Insights

  • 3.1 Industry ecosystem analysis
    • 3.1.1 Factor affecting the value chain
    • 3.1.2 Profit margin analysis
    • 3.1.3 Disruptions
    • 3.1.4 Future outlook
    • 3.1.5 Manufacturers
    • 3.1.6 Distributors
  • 3.2 Supplier landscape
  • 3.3 Profit margin analysis
  • 3.4 Key news & initiatives
  • 3.5 Regulatory landscape
  • 3.6 Impact forces
  • 3.7 Industry impact forces
    • 3.7.1 Growth drivers
      • 3.7.1.1 Rising incidence of orthopedic and dental surgeries.
      • 3.7.1.2 Increasing demand for minimally invasive procedures.
      • 3.7.1.3 Advancements in polymer technology and biocompatibility.
    • 3.7.2 Market challenges
      • 3.7.2.1 Regulatory hurdles and lengthy approval processes.
  • 3.8 Regulations & market impact
  • 3.9 Porter's analysis
  • 3.10 PESTEL analysis

Chapter 4 Competitive Landscape, 2024

  • 4.1 Introduction
  • 4.2 Company market share analysis
  • 4.3 Competitive positioning matrix
  • 4.4 Strategic outlook matrix

Chapter 5 Market Size and Forecast, By Polymer, 2021-2034 (USD Million) (Tons)

  • 5.1 Key trends
  • 5.2 Synthetic
    • 5.2.1 PLA
    • 5.2.2 PG
    • 5.2.3 PCL
  • 5.3 Natural
    • 5.3.1 Chitosan
    • 5.3.2 Collagen

Chapter 6 Market Size and Forecast, By Application, 2021-2034 (USD Million) (Tons)

  • 6.1 Key trends
  • 6.2 Joint reconstruction
  • 6.3 Spine
  • 6.4 Craniomaxillofacial
  • 6.5 Orthobiologics
  • 6.6 Dental
  • 6.7 Others

Chapter 7 Market Size and Forecast, By Region, 2021-2034 (USD Million) (Tons)

  • 7.1 Key trends
  • 7.2 North America
    • 7.2.1 U.S.
    • 7.2.2 Canada
  • 7.3 Europe
    • 7.3.1 UK
    • 7.3.2 Germany
    • 7.3.3 France
    • 7.3.4 Italy
    • 7.3.5 Spain
    • 7.3.6 Russia
  • 7.4 Asia Pacific
    • 7.4.1 China
    • 7.4.2 India
    • 7.4.3 Japan
    • 7.4.4 South Korea
    • 7.4.5 Australia
  • 7.5 Latin America
    • 7.5.1 Brazil
    • 7.5.2 Mexico
  • 7.6 MEA
    • 7.6.1 South Africa
    • 7.6.2 Saudi Arabia
    • 7.6.3 UAE

Chapter 8 Company Profiles

  • 8.1 BMG Incorporated
  • 8.2 Corbion N.V.
  • 8.3 Evonik
  • 8.4 Foster Corporation
  • 8.5 KLS Martin
  • 8.6 Lactel Absorbable Polymers
  • 8.7 Medtronic
  • 8.8 NuVasive
  • 8.9 Polysciences
  • 8.10 Zimmer Biomet